| NEJM: Apixaban better than warfarin to treat atrial fibrillation. |
|
| NEJM: Conclusions. In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality. |